Search all trials

Find therapies in clinical trials near you – page 47

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Chronic myeloid leukaemia

Not recruiting

Registered drugNo placebo

Study on the Tolerability and Efficacy of Asciminib vs. Nilotinib for Adults with Newly Diagnosed Philadelphia Chromosome Positive Chronic Myeloid Leukemia

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Nilotinib

Contact Research Centre

Primary amyloidosis

Not recruiting

Registered drugNo placebo

Study on Daratumumab, Cyclophosphamide, Bortezomib, and Dexamethasone for Patients with Newly Diagnosed Systemic AL Amyloidosis

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Bortezomib

Contact Research Centre

Study on the Effects of NMRA-335140 for Adults with Major Depressive Disorder

Not recruiting

Investigational

Study on the Effects of NMRA-335140 for Adults with Major Depressive Disorder

Investigational

France

Participants:18–64 years
Substances:1-[6-Ethyl-8-Fluoro-4-Methyl-3-(3-Methyl-1,2,4-Oxadiazol-5-Yl)Quinolin-2-Yl]-N-(Oxan-4-Yl)Piperidin-4-Amine

Contact Research Centre

Parkinson's disease

Not recruiting

InvestigationalNo placebo

Study on the Long-Term Safety of ND0612 (Carbidopa, Levodopa) Infusion for Patients with Advanced Parkinson's Disease

InvestigationalNo placebo

France

Participants:18–64 years · 65+ years
Substances:Carbidopa

Contact Research Centre

Study on Long-term Safety and Effectiveness of NMRA-335140 for Patients with Major Depressive Disorder

Not recruiting

InvestigationalNo placebo

Study on Long-term Safety and Effectiveness of NMRA-335140 for Patients with Major Depressive Disorder

InvestigationalNo placebo

France

Participants:18–64 years
Substances:1-[6-Ethyl-8-Fluoro-4-Methyl-3-(3-Methyl-1,2,4-Oxadiazol-5-Yl)Quinolin-2-Yl]-N-(Oxan-4-Yl)Piperidin-4-Amine

Contact Research Centre

Plasma cell myeloma

Not recruiting

Registered drugNo placebo

Study on the Effectiveness and Safety of Cevostamab and Tocilizumab for Patients with Relapsed or Refractory Multiple Myeloma

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Cevostamab

Contact Research Centre

Chronic lymphocytic leukaemia

Not recruiting

Registered drugNo placebo

Study Comparing Pirtobrutinib with Idelalisib and Rituximab or Bendamustine and Rituximab for Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Idelalisib

Contact Research Centre

Waldenstrom's macroglobulinaemia

Not recruiting

Registered drugNo placebo

Study of CLR 131 for Patients with Relapsed or Refractory Waldenstrom Macroglobulinemia

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Levothyroxine Sodium

Contact Research Centre

Non-small cell lung cancer

Not recruiting

InvestigationalNo placebo

Study on the Safety and Effectiveness of Sunvozertinib for Patients with Advanced Non-Small Cell Lung Cancer with EGFR or HER2 Mutations

InvestigationalNo placebo

France

Participants:18–64 years · 65+ years
Substances:Sunvozertinib

Contact Research Centre

Myocarditis

Not recruiting

InvestigationalNo placebo

Study on the Effect of Cannabidiol (CardiolRx) on Heart Recovery in Patients with Acute Myocarditis

InvestigationalNo placebo

France

Participants:18–64 years · 65+ years
Substances:Cannabidiol

Contact Research Centre

HER2 positive breast cancer

Not recruiting

Registered drugNo placebo

Study Comparing Trastuzumab Deruxtecan and Trastuzumab Emtansine for Patients with High-Risk HER2-Positive Breast Cancer with Residual Disease After Initial Treatment

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Trastuzumab Deruxtecan

Contact Research Centre

Coronary artery disease

Not recruiting

Registered drug

Study on Inclisiran and Statin Therapy for Patients with Non-obstructive Coronary Artery Disease to Assess Atherosclerotic Plaque Progression

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Atorvastatin

Contact Research Centre

Find therapies in clinical trials near you – page 47

619 trials match your criteria

Chronic myeloid leukaemia

Study on the Tolerability and Efficacy of Asciminib vs. Nilotinib for Adults with Newly Diagnosed Philadelphia Chromosome Positive Chronic Myeloid Leukemia

Primary amyloidosis

Study on Daratumumab, Cyclophosphamide, Bortezomib, and Dexamethasone for Patients with Newly Diagnosed Systemic AL Amyloidosis

Study on the Effects of NMRA-335140 for Adults with Major Depressive Disorder

Study on the Effects of NMRA-335140 for Adults with Major Depressive Disorder

Parkinson's disease

Study on the Long-Term Safety of ND0612 (Carbidopa, Levodopa) Infusion for Patients with Advanced Parkinson's Disease

Study on Long-term Safety and Effectiveness of NMRA-335140 for Patients with Major Depressive Disorder

Study on Long-term Safety and Effectiveness of NMRA-335140 for Patients with Major Depressive Disorder

Plasma cell myeloma

Study on the Effectiveness and Safety of Cevostamab and Tocilizumab for Patients with Relapsed or Refractory Multiple Myeloma

Chronic lymphocytic leukaemia

Study Comparing Pirtobrutinib with Idelalisib and Rituximab or Bendamustine and Rituximab for Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Waldenstrom's macroglobulinaemia

Study of CLR 131 for Patients with Relapsed or Refractory Waldenstrom Macroglobulinemia

Non-small cell lung cancer

Study on the Safety and Effectiveness of Sunvozertinib for Patients with Advanced Non-Small Cell Lung Cancer with EGFR or HER2 Mutations

Myocarditis

Study on the Effect of Cannabidiol (CardiolRx) on Heart Recovery in Patients with Acute Myocarditis

HER2 positive breast cancer

Study Comparing Trastuzumab Deruxtecan and Trastuzumab Emtansine for Patients with High-Risk HER2-Positive Breast Cancer with Residual Disease After Initial Treatment

Coronary artery disease

Study on Inclisiran and Statin Therapy for Patients with Non-obstructive Coronary Artery Disease to Assess Atherosclerotic Plaque Progression

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.